Propagative α-synuclein seeds as serum biomarkers for synucleinopathiesAyami Okuzumi, Nobutaka Hattori, Taiji Tsunemi et al.|Nature Medicine|2023Cited by 321
A metabolic profile of polyamines in parkinson disease: A promising biomarkerShinji Saiki, Nobutaka Hattori, Shin‐Ichi Ueno et al.|Annals of Neurology|2019Cited by 123
Serum caffeine and metabolites are reliable biomarkers of early Parkinson diseaseMotoki Fujimaki, Nobutaka Hattori, Takahiro Koinuma et al.|Neurology|2018Cited by 103